Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
plenty of opportunities in the company for a dedicated employee who are capable and full of ideas
Qual è la parte migliore del tuo compenso?
flexible working hours, comparable benefits in biotech
Cosa ti piace di più del team di leadership?
vision, hands-on, determined, quick decisions
Quali sono alcune delle cose migliori della tuo team?
dedicated, learn quickly, collaborative style
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
innovative thinking, making impossible possible
Che cosa ti rende più felice sul posto di lavoro?
challenges possibly meet every day opportunity to provide scientific suggestions and strategies which will make significant impact on the pipeline and company growth
Other Employee Reviews for Karyopharm Therapeutics
×